10.1002/ejoc.201701714
European Journal of Organic Chemistry
FULL PAPER
reflections, θmax 25.242°, 163 refined parameters, maximum residual
electron density 0.189 and −0.213 e.Å-3. R1=0.0417, wR2=0.1037.
8a-H), 2.40 (1H, br s, OH), 2.31 (1H, q, J 8.8 Hz, 1H, 3-H"), 2.03 (1H, dd,
J 13.8 and 2.7 Hz, 8-H'), 1.95–1.66 (ca 5H, m, 1-H', 2-H', 2-H", 8-H" and
H2O), 1.39 (1H, qd, J 11.1 and 6.6 Hz, 1-H"); 13C NMR (75 MHz, CDCl3)
δ 144.6 (Ar C-1), 128.9 (Ar o- or m-C), 128.1 (Ar p-C), 124.4 (Ar o- or m-
C), 118.5 (C≡N), 73.4 (C-7), 58.6 (C-8a), 53.1 (C-3), 50.7 (C-5), 44.3 (C-
8), 40.2 (C-6), 30.0 (C-1), 21.2 (C-2); HRMS (EI): M+, found 242.1412.
[C15H18N2O]+ requires 242.1414. X-ray crystal structure details of
compound 13a: crystallised from hexane–EtOAc, formula: C15H20N2O2,
M=260.33, colour of crystal: colourless, block, crystal size 0.40 × 0.38 ×
0.18 mm3, a=8.287(1) Å, b=13.2796(14) Å, c=13.3083(15) Å,
3-[2-(2-Oxo-2-phenylethyl)-1-pyrrolidinyl]propanenitrile
(7): This
compound was prepared by adapting a reported procedure.[12] 3-{2-[(E)-
2-Oxo-2-phenylethylidene]-1-pyrrolidinyl}propanenitrile (6) (5.00 g, 20.8
mmol) in THF (150 cm3) was cooled to −10 °C and stirred under an
atmosphere of Ar for 10 min. LiAlH4 (95%, 790 mg, ca 20 mmol) was
added in one portion and stirring was continued for 15 min. EtOAc (20
cm3) was added followed by H2O (3 cm3). Once the solution went white
Na2SO4 was added and stirring was continued for 20 mins. The reaction
mixture was filtered through a pad of Celite and the pad was rinsed with
EtOAc (4 × 50 cm3). Evaporation of the solvents afforded a yellow oil that
was purified by flash chromatography (70% EtOAc/hexane) to afford the
title compound 7 (4.32 g, 86%) as a yellow oil, as well as a small quantity
of (Z)-1-phenyl-2-(2-pyrrolidinylidene)-1-ethanone (12) (100 mg, <3%) as
a colourless solid. Compound 7: Rf (EtOAc) 0.51; FTIR (liquid film) νmax
3060 (w), 2963 (m), 2813 (m), 2248 (w, C≡N), 1682 (s, C=O) 1597 (m),
β=102.566(2)° V=1429.5(3) Å3,
ρ
calc=1.210 Mg/m3, µ=0.081 mm-1,
F(000)=560, Z=4, monoclinic, space group P21/n, T=293(2) K, 8068
reflections collected, 2804 independent reflections, θmax 25.242°, 181
refined parameters, maximum residual electron density 0.124 and −0.191
e.Å-3. R1=0.0386, wR2=0.0936.
Method 2: t-BuOK (2.42 g, 21.5 mmol) was added to a solution of 3-[2-
(2-oxo-2-phenylethyl)-1-pyrrolidinyl]propanenitrile (7) (2.37 g, 9.78 mmol)
in dry THF (50 cm3) and stirred under N2 at room temperature for 3 h.
Workup and chromatography as described above afforded an orange
solid (2.15 g). Rapid recrystallization from chilled (−10 °C) EtOAc/hexane
1580 (m), 1449 (m), 1210 (m) cm−1 1H NMR (300 MHz, CDCl3) δ 7.97
;
(2H, d with fine coupling, J ca 7.2 Hz, Ar o-H), 7.57 (1H, t with fine
coupling, J ca 7.3 Hz, Ar p-H), 7.47 (2H, t with fine coupling, J ca 7.4 Hz,
Ar m-H), 3.26 (1H, dd, J 16.1 and 4.1 Hz, CHaHbC=O), 3.20–3.07 (3H, m,
ring 2-H, ring NCH, ring NCHaHb, chain NCHaHb), 3.02 (1H, dd, J 16.1
and 7.8 Hz, CHaHbC=O), 2.61 (1H, ddd, J 12.1, 6.8 and 5.5 Hz, chain
NCHaHb), 2.50 (2H, dd, J 7.5 and 5.9 Hz, CH2CN), 2.30 (1H, q, J 8.5 Hz,
ring NCHaHb), 2.13 (1 H, ddt, J 12.6, 8.9 and 7.3 Hz, ring 3-Ha), 1.90–
1.75 (2H, m, ring 4-H), 1.50 (1H, ddt, J 12.6, 8.6 and 6.2 Hz, ring 3-Hb);
13C NMR (75 MHz, CDCl3) δ 199.3 (C=O), 137.1 (Ar C-1), 133.2 (Ar p-C),
128.6 and 128.0 (Ar o- and m-C), 118.9 (C≡N), 60.1 (ring NCH), 53.3
(ring NCH2), 49.8 (chain NCH2), 44.1 (CH2C=O), 31.4 (ring C-3), 22.8
(ring C-4), 17.7 (CH2CN). The 1H and 13C NMR spectroscopic data are in
line with those previously reported at 200 MHz and 50 MHz,
respectively.[12] Compound 12: mp 114–116 °C (acetone) (lit.,[12] 115.5–
117.5 °C); 1H NMR (300 MHz, CDCl3) δ 10.28 (1H, br s, NH), 7.92–7.82
(2H, m, Ar-H), 7.44–7.34 (3H, m, Ar-H), 5.81 (1H, s, =CH), 3.65 (2H, t, J
7.0 Hz, NCH2), 2.74 (2H, t, J 7.8 Hz, CH2C=), 2.12–1.96 (2H, m, ring 4-
H); 13C NMR (75 MHz, CDCl3) δ 188.03 (C=O), 169.15 (C=CH), 140.33
(Ar C-1), 130.68 (Ar p-C), 128.09 and 126.95 (Ar o- and m-C), 86.47
(C=CH), 47.67 (NCH2), 32.83 (CH2C=), 21.36 (CH2CH2CH2). The 1H and
13C NMR spectroscopic data agree with those previously reported at 200
MHz and 50 MHz, respectively.[12]
mixtures
afforded
rel-(6R,7R,8aR)-7-hydroxy-7-
phenyloctahydroindolizine-6-carbonitrile that appeared to be
a
hemihydrate by NMR spectroscopy (1.72 g, ca 70%). This hydrate could
be converted into the crystalline monohydrate by recrystallization from
aqueous acetone.
rel-(6R,7S,8aS)-7-Hydroxy-7-phenyloctahydroindolizine-6-
carbonitrile (13b)
Method 1: t-BuOK (277 mg, 2.47 mmol) was added to a solution of the
monohydrate of rel-(6R,7R,8aR)-7-hydroxy-7-phenyloctahydroindolizine-
6-carbonitrile hydrate (13a) (536 mg, 2.06 mmol) in dry THF (25 cm3),
and the mixture was stirred under argon at room temperature for 21 h,
and then at 40–50 °C for an additional 48 h. The solvent was evaporated
and the residue was taken into EtOAc (25 cm3) and washed with H2O (10
cm3) and brine (10 cm3). The organic extract was dried over Na2SO4,
filtered and evaporated to afford an orange gum. Flash chromatography
(50% EtOAc/hexane) afforded the title compound 13b (79 mg, 16%) as a
solid. Further elution of the column afforded recovered starting material
(237 mg, 44% mass recovery). Compound 13b: mp 136–138 °C; Rf
(EtOAc) 0.75; FTIR (ATR) νmax 3472 (s, H-bonded OH), 2843 and 2826
(s, Bohlmann bands), 2248 (w, C≡N), 1665 (m), 1493 (s), 1336 (s), 1045
rel-(6R,7R,8aR)-7-Hydroxy-7-phenyloctahydroindolizine-6-
carbonitrile monohydrate (13a)
(s) cm−1 1H NMR (300 MHz, CDCl3) δ 7.57 (2H, d, J 7.6 Hz, Ar o-H),
;
7.43–7.32 (3H, m, Ar m- and p-H), 3.19 (1H, dd, J 11.4 and 2.1 Hz, 5-H'),
3.13 (1H, td, J 8.6 and 2.5 Hz, 3-H'), 2.98 (1H, q, J 2.3 Hz, 6-H), 2.80 (1H,
dd, J 11.2 and 2.8 Hz, 5-H"), 2.47 (1H, td, J 11.1 and 5.6 Hz, 8a-H), 2.34
(1H, t, J 12.0 Hz, 8-H'), 2.25 (1H, t, J 8.7 Hz, 3-H"), 2.01 (1H, dt, J 12.0
and 2.3 Hz, 8-H"), 1.98–1.85 (3H, m, 1-H', 2-H' and OH), 1.82–1.68 (1H,
m, 2-H"), 1.57 (1H, qd, J 10.9 and 6.1 Hz, 1-H"); 13C NMR (75 MHz,
CDCl3) δ 144.3 (Ar C-1), 128.7 (Ar o- or m-C), 128.5 (Ar p-C), 125.3 (Ar
o- or m-C), 120.0 (C≡N), 73.0 (C-7), 58.3(C-8a), 53.0 (C-3), 50.1 (C-5),
41.0 (C-6), 38.9 (C-8), 30.3 (C-1), 21.3 (C-2); HRMS (EI): M+, found
242.1421. [C15H18N2O]+ requires 242.1414. X-ray crystal structure details
of compound 13b: crystallised from hexane–EtOAc, formula: C15H18N2O,
M=242.31, colour of crystal: colourless, plate, crystal size 0.36 × 0.32 ×
0.11 mm3, a=6.412(2) Å, b=13.228(4) Å, c=7.460(2) Å, β=90.017(7)°,
V=632.7(3) Å3, ρcalc=1.272 Mg/m3, µ=0.081 mm-1, F(000)=260, Z=2,
monoclinic, space group P21, T=173(2) K, 5573 reflections collected,
2713 independent reflections, θmax 25.242°, 165 refined parameters,
maximum residual electron density 0.138 and −0.154 e.Å-3. R1=0.0311,
wR2=0.0753.
Method 1: t-BuOK (3.64 g, 32.3 mmol) was added to a solution of 3-[2-
(2-oxo-2-phenylethyl)-1-pyrrolidinyl]propanenitrile (7) (3.85 g, 15.9 mmol)
in dry THF (100 cm3) and stirred under N2 at room temperature for 3 h.
The solvent was evaporated and the residue partitioned between brine
(100 cm3) and EtOAc (200 cm3) and stirred for 15 min. The organic
extracts were combined and washed with additional brine (4 × 100 cm3),
and then dried over Na2SO4, filtered and evaporated to afford an orange
oil. Column chromatography (60% EtOAc/hexane) afforded impure
product as an orange solid (3.065 g, ca 80%). Slow recrystallization from
hot 30% EtOAc/hexane afforded the monohydrate of the title compound
13a (2.23 g, 8.57 mmol, 54%) as a colourless solid. Attempts to isolate
additional products from the mother liquors resulted in decomposition to
a black tar. Compound 13a monohydrate: mp 118–119 °C (30%
EtOAc/hexane); Rf (EtOAc) 0.51; FTIR (ATR) νmax 3508 (s, H-bonded
OH), 3192 (br, m, OH), 2946 (s), 2874 (s), 2826 (s), 2256 (w, C≡N), 1447
(m), 1383 (m), 1343 (m), 1217 (s) cm−1; 1H (300 MHz, CDCl3) δ 7.50 (2H,
d, J 7.5 Hz, Ar o-H), 7.41 (2H, t, J 7.4 Hz, Ar m-H), 7.33 (1H t, J 7.1 Hz,
Ar p-H), 3.36–3.28 (2H, m, 5-H' and 6-H), 3.10 (1H, td, J 8.6 and 2.5 Hz,
3-H'), 2.79 (1H, t, J 12.4 Hz, 5-H"), 2.48 (1H, tdd, J 10.9, 5.8 and 2.6 Hz,
This article is protected by copyright. All rights reserved.